# Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure

> **NCT07220902** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Nebraska Methodist Health System** · enrollment: 1240 (estimated)

## Conditions studied

- Severe Preeclampsia
- Eclampsia Preeclampsia

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** magnesium sulfate

## Key facts

- **NCT ID:** NCT07220902
- **Lead sponsor:** Nebraska Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2033-12-31
- **Final completion:** 2034-07
- **Target enrollment:** 1240 (ESTIMATED)
- **Last updated:** 2025-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07220902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07220902, "Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07220902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*